These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1161 related items for PubMed ID: 18052753

  • 1. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 2. PTH circadian rhythm and PTH target-organ sensitivity is altered in patients with adult growth hormone deficiency with low BMD.
    White HD, Ahmad AM, Durham BH, Peter R, Prabhakar VK, Corlett P, Vora JP, Fraser WD.
    J Bone Miner Res; 2007 Nov; 22(11):1798-807. PubMed ID: 17645402
    [Abstract] [Full Text] [Related]

  • 3. Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients.
    White HD, Ahmad AM, Syed AA, Clewes A, Peter R, Vora JP, Fraser WD.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):516-26. PubMed ID: 15049968
    [Abstract] [Full Text] [Related]

  • 4. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency.
    Ahmad AM, Hopkins MT, Fraser WD, Ooi CG, Durham BH, Vora JP.
    Bone; 2003 Feb; 32(2):170-9. PubMed ID: 12633789
    [Abstract] [Full Text] [Related]

  • 7. Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity.
    White HD, Ahmad AM, Durham BH, Chandran S, Patwala A, Fraser WD, Vora JP.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):913-9. PubMed ID: 16352693
    [Abstract] [Full Text] [Related]

  • 8. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF.
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [Abstract] [Full Text] [Related]

  • 9. Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women.
    Lieberman SA, Holloway L, Marcus R, Hoffman AR.
    J Bone Miner Res; 1994 Nov; 9(11):1723-8. PubMed ID: 7863823
    [Abstract] [Full Text] [Related]

  • 10. The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion.
    Joseph F, Chan BY, Durham BH, Ahmad AM, Vinjamuri S, Gallagher JA, Vora JP, Fraser WD.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3230-8. PubMed ID: 17550963
    [Abstract] [Full Text] [Related]

  • 11. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
    Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, Glass EV, Myers SL, Krege JH.
    J Bone Miner Res; 2005 Nov; 20(11):1905-11. PubMed ID: 16234962
    [Abstract] [Full Text] [Related]

  • 12. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women.
    Kärkkäinen M, Lamberg-Allardt C.
    J Bone Miner Res; 1996 Dec; 11(12):1905-12. PubMed ID: 8970892
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone replacement is important for the restoration of parathyroid hormone sensitivity and improvement in bone metabolism in older adult growth hormone-deficient patients.
    White HD, Ahmad AM, Durham BH, Patwala A, Whittingham P, Fraser WD, Vora JP.
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3371-80. PubMed ID: 15741264
    [Abstract] [Full Text] [Related]

  • 14. Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiency.
    White HD, Ahmad AM, Durham BH, Joshi AA, Fraser WD, Vora JP.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):726-36. PubMed ID: 21252245
    [Abstract] [Full Text] [Related]

  • 15. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
    Brixen K, Kassem M, Nielsen HK, Loft AG, Flyvbjerg A, Mosekilde L.
    J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
    [Abstract] [Full Text] [Related]

  • 16. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial.
    Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R.
    J Bone Miner Res; 2002 Jun; 17(6):1081-94. PubMed ID: 12054164
    [Abstract] [Full Text] [Related]

  • 17. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency.
    de Boer H, Blok GJ, Popp-Snijders C, Sips A, Lips P, van der Veen E.
    J Bone Miner Res; 1998 Feb; 13(2):245-52. PubMed ID: 9495517
    [Abstract] [Full Text] [Related]

  • 18. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism.
    Ho KK, Weissberger AJ.
    J Bone Miner Res; 1992 Jul; 7(7):821-7. PubMed ID: 1642149
    [Abstract] [Full Text] [Related]

  • 19. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G, Izzo G, La Montagna G, Bellastella A.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
    [Abstract] [Full Text] [Related]

  • 20. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.